You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

CLINICAL TRIALS PROFILE FOR AMERGE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for AMERGE

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00487578 ↗	Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction	Terminated	Clinvest	Phase 4	2006-10-01	The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
NCT00487578 ↗	Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction	Terminated	GlaxoSmithKline	Phase 4	2006-10-01	The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
NCT00487578 ↗	Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction	Terminated	Cady, Roger, M.D.	Phase 4	2006-10-01	The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
NCT01332383 ↗	Special Drug Use Investigation for AMERGE® Tablet (Long-term)	Completed	GlaxoSmithKline		2009-05-01	To investigate the long-term safety and efficacy of AMERGE (naratriptan hydrochloride) on Japanese patients with migraine headache in clinical setting
NCT01376193 ↗	Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet	Completed	GlaxoSmithKline		2009-04-01	The study is designed to investigate the information on safety and efficacy of naratriptan tablets on Japanese subjects with migraine headache during Japanese post-marketing surveillance period.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for AMERGE

Condition Name

Chart
Table

Condition Name for AMERGE
Intervention	Trials
Migraine Disorders	2
Migraine	1
Post Traumatic Headache	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for AMERGE
Intervention	Trials
Migraine Disorders	3
Post-Traumatic Headache	1
Headache	1
Cognitive Dysfunction	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for AMERGE

Trials by Country

Map
Table

Trials by Country for AMERGE
Location	Trials
United States	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for AMERGE
Location	Trials
Connecticut	1
Texas	1
North Carolina	1
Missouri	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for AMERGE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for AMERGE
Clinical Trial Phase	Trials
Phase 4	1
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for AMERGE
Clinical Trial Phase	Trials
Completed	2
Terminated	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMERGE

Sponsor Name

Chart
Table

Sponsor Name for AMERGE
Sponsor	Trials
GlaxoSmithKline	3
Clinvest	1
Cady, Roger, M.D.	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for AMERGE
Sponsor	Trials
Other	3
Industry	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.